| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |